Evidence map›Paper›PMID 20142183›Full record

Trial reportEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2009

Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).

Irene M Lang, Sandra A Forman, Aldo P Maggioni, Witold Ruzyllo, Jean Renkin, Carlos Vozzi, P Gabriel Steg, Jose-Maria Hernandez-Garcia, Krzysztof Zmudka, Manuel Jimenez-Navarro and 3 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00004562 phase3completednot on this map

Occluded Artery Trial (OAT) - Randomized Comparative Effectiveness Trial of PCI and Medical Therapy Only Post MI

TypeinterventionalSponsorNYU Langone HealthRan1999 to 2011Enrolled2,201ConditionsCardiovascular Diseases, Heart Diseases, Myocardial Infarction, Heart Failure, CongestiveArmsBeta adrenergic blockers, Platelet inhibitors, PTCA and stents, ACE Inhibitors
NCT03848429 completednot on this mapstarted 2019, after this paper: background citation

Mechanical Complications of Acute Myocardial Infarction: an International Multicenter Cohort Study (CAUTION Study 1)

TypeobservationalSponsorMaastricht University Medical CenterRan2019 to 2020Enrolled300ConditionsPost-Infarction Heart Rupture, Post-Infarction Ventricular Septal Defect, Post-Infarction Mitral Papillary Muscle RuptureArmsSurgery for mechanical complications of acute myocardial infarction
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Association of Helicobacter pylori infection with coronary artery disease: is it an independent risk factor?The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2021
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Irene M LangMedical University of Vienna, Vienna, Austria. irene.lang@meduniwien.ac.at
Sandra A Forman
Aldo P Maggioni
Witold Ruzyllo
Jean Renkin
Carlos Vozzi
P Gabriel Steg
Jose-Maria Hernandez-Garcia
Krzysztof Zmudka
Manuel Jimenez-Navarro
George Sopko
Gervasio A Lamas
Judith S Hochman
Medical University of Vienna · AT

Funding

Occluded Artery Trial: Long Term Follow-UpU01HL062509 · NHLBI · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI HOCHMAN, JUDITH S · 1999 to 2010
$11.1M
Occluded Artery Trial: Long-Term Follow up-Data Coordinating CenterU01HL062511 · NHLBI · MARYLAND MEDICAL RESEARCH INSTITUTE, INC · PI FORMAN, SANDRA · 1999 to 2010
$5.2M
NHLBI NIH HHS U01 HL062509NHLBI NIH HHS U01 HL062511
6 · The paper itself

Abstract

aimsOAT randomised patients with an occluded infarct artery three to 28 days after myocardial infarction (MI). The study demonstrated that PCI did not reduce the occurrence of the primary composite endpoint of death, re-MI, and New York Heart Association class IV heart failure in comparison with patients assigned to optimal medical therapy alone (MED). In view of prior literature in similar cohorts showing fewer sudden cardiac deaths and less left ventricular (LV) remodelling, but excess re-MI with PCI, causes of death were analysed in more detail. METHODS AND

resultsStepwise Cox regression was used to examine baseline variables associated with causes of death. The immediate and primary cause of death did not differ between 1,101 PCI and 1,100 MED patients. One-year cardiovascular death rates were 3.8% for the PCI group, and 3.7% for the MED group, and 0.9% per year for the next four years in both groups. Five of six cases of cardiac rupture occurred in patients undergoing PCI.

conclusionsIn stable post-MI patients with occlusion of the infarct-related artery, PCI did not change the rate or cause of death. The observation that the majority of cardiac ruptures occurred in patients undergoing PCI deserves further investigation.

Indexed as

SurvivorsAdultAgedAged, 80 and overAngioplasty, Balloon, CoronaryCause of DeathChi-Square DistributionCoronary AngiographyCoronary OcclusionFemaleHeart FailureHeart Rupture, Post-InfarctionHumansKaplan-Meier EstimateMaleMiddle Aged

Identifiers

PMID20142183
PMCPMC2893563
OpenAlexW2050190575

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.